Zobrazeno 1 - 10
of 12
pro vyhledávání: '"James J. Isaacs"'
Publikováno v:
Energy & Fuels. 15:769-775
Reaction rates of coals are often limited by the mass transfer rates of reagents into coals. The reaction of tetralkylammonium hydroxides with coals giving coal polyanions is much more rapid than any other derivatization of coal's hydroxyl groups. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32bd937df1c9a5e49300b8f4ee3869f6
https://doi.org/10.1021/ef000193b
https://doi.org/10.1021/ef000193b
Publikováno v:
The Journal of Organic Chemistry. 50:5560-5566
Reactions within three-dimensional organic matrices are often controlled by diffusion processes. Bituminous coal was treated with a series of tetra-n-alkylammonium hydroxides (R/sub 4/NOH, R = methyl, ethyl, n-propyl, n-butyl, n-hexyl, and n-octyl) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c46c2d9d1e38ba4a5a356855e3736d77
https://doi.org/10.1021/jo00350a026
https://doi.org/10.1021/jo00350a026
Publikováno v:
Fuel. 62:781-791
The exposure of freshly-mined Illinois No.6 bituminous coal (Monterey Mine No.1) to atmospheric oxygen at ambient conditions resulted in a slow oxidation reaction which appeared to be complete within two months to produce an oxidized coal product wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f4c0d7ba9e27406e2e3a145b396d61a
https://doi.org/10.1016/0016-2361(83)90028-5
https://doi.org/10.1016/0016-2361(83)90028-5
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dima D; Department of Hematology-Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Lopetegui-Lia N; Department of Hematology-Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Ogbue O; Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Osantowski B; Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Ullah F; Department of Hematology-Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Jia X; Department of Biostatistics, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Song JM; Department of Hematology-Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Gastman B; Department of Plastic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Isaacs J; Department of Hematology-Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Kennedy LB; Department of Hematology-Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Funchain P; Department of Hematology-Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.; Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (12), pp. e7257.
Autor:
Ding S; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Xilis, Inc., Durham, NC 27713, USA., Hsu C; College of Arts and Sciences, University of Chapel Hill, Chapel Hill, NC 27599, USA., Wang Z; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Xilis, Inc., Durham, NC 27713, USA., Natesh NR; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Millen R; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Negrete M; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Giroux N; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Rivera GO; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Dohlman A; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Bose S; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Rotstein T; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Spiller K; Xilis, Inc., Durham, NC 27713, USA., Yeung A; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Sun Z; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Jiang C; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA., Xi R; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Wilkin B; Xilis, Inc., Durham, NC 27713, USA., Randon PM; National Institute of Environmental Health Sciences (NIEHS), Durham, NC 27709, USA., Williamson I; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA., Nelson DA; Xilis, Inc., Durham, NC 27713, USA., Delubac D; Xilis, Inc., Durham, NC 27713, USA., Oh S; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA., Rupprecht G; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA., Isaacs J; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA., Jia J; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA., Chen C; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA., Shen JP; Department of Gastrointestinal Medical Oncology, MD Anderson, Houston, TX 77030, USA., Kopetz S; Department of Gastrointestinal Medical Oncology, MD Anderson, Houston, TX 77030, USA., McCall S; Department of Pathology, Duke University, Durham, NC 27708, USA., Smith A; Xilis, Inc., Durham, NC 27713, USA., Gjorevski N; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel 4058, Switzerland., Walz AC; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel 4058, Switzerland., Antonia S; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA., Marrer-Berger E; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel 4058, Switzerland., Clevers H; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel 4058, Switzerland. Electronic address: h.clevers@hubrecht.eu., Hsu D; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC 27708, USA. Electronic address: shiaowen.hsu@duke.edu., Shen X; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA. Electronic address: xiling.shen@terasaki.org.
Publikováno v:
Cell stem cell [Cell Stem Cell] 2022 Jun 02; Vol. 29 (6), pp. 905-917.e6. Date of Electronic Publication: 2022 May 03.
Autor:
Isaacs J; Division of Medical Oncology, Duke Cancer Institute, Duke University Medical Center, DUMC 3841, Durham, NC, 27710, USA. james.isaacs@duke.edu., Stinchcombe TE; Division of Medical Oncology, Duke Cancer Institute, Duke University Medical Center, DUMC 3841, Durham, NC, 27710, USA.
Publikováno v:
Drugs [Drugs] 2022 Jun; Vol. 82 (8), pp. 855-863. Date of Electronic Publication: 2022 May 21.
Autor:
Isaacs J; Duke University, Durham, North Carolina., Tan AC; National Cancer Centre Singapore and Duke-NUS Medical School, Singapore., Hanks BA; Duke University, Durham, North Carolina., Wang X; Duke University, Durham, North Carolina., Owzar K; Duke University, Durham, North Carolina., Herndon JE 2nd; Duke University, Durham, North Carolina., Antonia SJ; Duke University, Durham, North Carolina., Piantadosi S; Brigham and Women's Hospital, Boston, Massachusetts., Khasraw M; Duke University, Durham, North Carolina. mustafa.khasraw@duke.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jan 01; Vol. 28 (1), pp. 13-22. Date of Electronic Publication: 2021 Jul 26.
Autor:
Isaacs J; Department of Medicine, Duke University Medical Center, Durham, NC., Welsby IJ; Department of Anesthesiology, Duke University Medical Center, Durham, NC., Schroder JN; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC., Onwuemene OA; Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, NC. Electronic address: toyosi.onwuemene@duke.edu.
Publikováno v:
Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2021 Nov; Vol. 35 (11), pp. 3299-3302. Date of Electronic Publication: 2020 Aug 27.